搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
药品
/
axsm
/
财务摘要
Axsome Therapeutics Inc
AXSM
添加自选
207.780
USD
-6.500
-3.03%
收盘 09-18 16:00(美东)
10.87B
总市值
亏损
市盈率 TTM
Axsome Therapeutics Inc
207.780
-6.500
-3.03%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
AXSM 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Axsome Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
10.87B
股息TTM
0.00
市盈率 TTM
-55.79
每股收益TTM
-3.73
营业收入
638.50M
净利润
-287.22M
净资产收益率
-349.38%
总资产收益率
-28.74%
Axsome Therapeutics Inc 财报日历
最新发布
8月 10, 2026
每股收益 / 预测值
-0.99
/-0.84
营业收入 / 预测值
218.38M
/221.23M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-2.10%
-0.99
-3.69%
-1.26
63.45%
-0.56
29.64%
-0.94
41.82%
-0.97
15.71%
-1.22
25.93%
-1.54
-1.66%
-1.34
-8.43%
-1.67
-459.58%
-1.44
-47.91%
-2.08
--
-1.32
--
-1.54
--
-0.26
--
-1.41
--
-3.17
--
--
--
--
--
--
--
--
营业收入
45.54%
218.38M
57.42%
191.20M
65.03%
196.00M
63.22%
170.99M
72.13%
150.04M
61.95%
121.46M
66.04%
118.77M
81.27%
104.76M
86.65%
87.17M
-20.70%
75.00M
193.50%
71.53M
243.08%
57.79M
429.49%
46.70M
--
94.58M
--
24.37M
--
16.85M
--
8.82M
--
--
--
--
--
--
净利润
-6.96%
-51.31M
-8.63%
-64.54M
61.88%
-28.56M
26.89%
-47.23M
39.54%
-47.97M
13.08%
-59.41M
24.06%
-74.91M
-3.86%
-64.60M
-18.13%
-79.34M
-509.35%
-68.36M
-61.09%
-98.65M
-38.77%
-62.20M
-62.10%
-67.17M
71.69%
-11.22M
-80.24%
-61.24M
-28.50%
-44.82M
-28.36%
-41.44M
-35.45%
-39.63M
-16.50%
-33.98M
-52.16%
-34.88M
利润率
26.51%
-23.50%
30.99%
-33.76%
76.90%
-14.57%
55.21%
-27.62%
64.88%
-31.97%
46.33%
-48.91%
54.27%
-63.08%
42.70%
-61.67%
36.71%
-91.03%
-668.41%
-91.14%
45.11%
-137.92%
--
-107.62%
--
-143.83%
--
-11.86%
--
-251.28%
--
-490.52%
--
--
--
--
--
--
--
--
毛利率
3.43%
93.06%
0.92%
91.48%
3.45%
92.89%
1.86%
92.09%
1.17%
89.98%
1.30%
90.65%
2.69%
89.79%
5.23%
90.41%
2.52%
88.93%
-0.96%
89.49%
4.09%
87.44%
--
85.92%
--
86.75%
--
90.35%
--
84.01%
--
78.81%
--
--
--
--
--
--
--
--
资产负债率
-12.01%
26.59%
-11.91%
27.59%
-13.39%
28.20%
-11.29%
29.11%
-9.74%
30.22%
-5.58%
31.32%
7.54%
32.55%
11.11%
32.81%
15.81%
33.48%
-12.55%
33.17%
6.46%
30.27%
--
29.53%
--
28.91%
--
37.93%
--
28.44%
--
27.71%
--
--
--
--
--
--
--
--
利润表
营业收入
45.54%
218.38M
57.42%
191.20M
65.03%
196.00M
63.22%
170.99M
72.13%
150.04M
61.95%
121.46M
66.04%
118.77M
81.27%
104.76M
86.65%
87.17M
-20.70%
75.00M
193.50%
71.53M
243.08%
57.79M
429.49%
46.70M
--
94.58M
--
24.37M
--
16.85M
--
8.82M
--
--
--
--
--
--
营业利润
-14.12%
-51.14M
-12.63%
-65.07M
41.55%
-36.02M
28.79%
-32.92M
40.94%
-44.82M
15.89%
-57.77M
-11.92%
-61.63M
25.79%
-46.23M
-28.61%
-75.89M
-950.90%
-68.69M
1.17%
-55.07M
-46.75%
-62.30M
-49.22%
-59.00M
82.93%
-6.54M
-70.87%
-55.72M
-27.08%
-42.45M
-28.18%
-39.54M
-37.51%
-38.29M
-17.53%
-32.61M
-58.13%
-33.41M
净利润
-6.96%
-51.31M
-8.63%
-64.54M
61.88%
-28.56M
26.89%
-47.23M
39.54%
-47.97M
13.08%
-59.41M
24.06%
-74.91M
-3.86%
-64.60M
-18.13%
-79.34M
-509.35%
-68.36M
-61.09%
-98.65M
-38.77%
-62.20M
-62.10%
-67.17M
71.69%
-11.22M
-80.24%
-61.24M
-28.50%
-44.82M
-28.36%
-41.44M
-35.45%
-39.63M
-16.50%
-33.98M
-52.16%
-34.88M
资产负债表
流动资产
22.35%
656.57M
23.57%
611.21M
21.42%
588.99M
18.00%
565.34M
15.89%
536.62M
7.41%
494.63M
-3.81%
485.06M
-6.38%
479.11M
-10.90%
463.03M
51.25%
460.49M
105.28%
504.26M
102.77%
511.76M
399.81%
519.69M
250.63%
304.45M
183.92%
245.64M
119.42%
252.38M
-26.60%
103.98M
-47.39%
86.83M
-52.99%
86.52M
-43.41%
115.02M
流动负债总额
34.59%
460.45M
80.07%
439.21M
64.64%
378.84M
83.65%
360.29M
83.36%
342.10M
69.33%
243.91M
65.72%
230.10M
71.10%
196.19M
62.27%
186.57M
43.11%
144.05M
43.80%
138.85M
90.21%
114.66M
170.08%
114.97M
309.99%
100.65M
318.64%
96.56M
143.99%
60.28M
86.19%
42.57M
13.22%
24.55M
-1.59%
23.07M
21.46%
24.71M
总资产
19.02%
761.45M
19.60%
713.61M
21.34%
689.80M
19.20%
669.25M
16.70%
639.78M
9.33%
596.67M
-3.36%
568.50M
-6.56%
561.46M
-10.37%
548.23M
40.23%
545.73M
77.46%
588.24M
77.27%
600.86M
238.75%
611.64M
339.45%
389.18M
277.60%
331.48M
190.71%
338.96M
26.03%
180.56M
-46.94%
88.56M
-52.84%
87.79M
-42.74%
116.60M
总负债
19.66%
678.14M
21.26%
659.02M
17.60%
601.51M
27.10%
595.52M
27.24%
566.71M
35.29%
543.47M
28.75%
511.48M
41.41%
468.56M
33.81%
445.37M
44.82%
401.69M
79.01%
397.26M
82.46%
331.35M
101.28%
332.83M
275.52%
277.37M
207.56%
221.92M
145.80%
181.60M
130.22%
165.36M
4.60%
73.86M
-0.26%
72.15M
8.06%
73.88M
总权益
14.00%
83.30M
2.60%
54.59M
54.86%
88.30M
-20.64%
73.73M
-28.95%
73.08M
-63.06%
53.20M
-70.15%
57.02M
-65.53%
92.90M
-63.11%
102.85M
28.82%
144.04M
74.32%
190.98M
71.27%
269.51M
1734.30%
278.80M
660.73%
111.81M
600.92%
109.56M
268.37%
157.36M
-78.72%
15.20M
-84.74%
14.70M
-86.26%
15.63M
-68.42%
42.72M
现金流量表
经营净额
-1.63%
-32.95M
52.28%
-20.70M
28.81%
-18.65M
105.61%
1.05M
-7.68%
-32.42M
18.88%
-43.38M
13.70%
-26.20M
65.21%
-18.63M
45.60%
-30.11M
-818.52%
-53.47M
-10.15%
-30.36M
-135.29%
-53.55M
-65.04%
-55.35M
82.17%
-5.82M
4.43%
-27.56M
15.01%
-22.76M
-32.07%
-33.54M
-19.98%
-32.65M
-40.32%
-28.84M
-70.17%
-26.78M
投资净额
-3361.54%
-450.00K
64.20%
-121.00K
-136.67%
-71.00K
35.56%
-58.00K
75.00%
-13.00K
-244.90%
-338.00K
-328.57%
-30.00K
75.74%
-90.00K
60.90%
-52.00K
-38.03%
-98.00K
96.13%
-7.00K
-461.64%
-371.00K
99.75%
-133.00K
66.78%
-71.00K
--
-180.86K
74.46%
-66.06K
-281944.07%
-53.24M
-612.57%
-213.74K
100.00%
0.00
-1642.52%
-258.68K
融资净额
39.38%
48.15M
-89.77%
2.99M
15.03%
16.39M
-30.05%
21.27M
140.24%
34.54M
2565.88%
29.27M
712300.00%
14.24M
-8.89%
30.41M
-94.16%
14.38M
-102.30%
-1.19M
-100.19%
-2.00K
-81.14%
33.37M
226.09%
246.08M
65.80%
51.56M
54.36%
1.07M
40236.54%
176.95M
3728.01%
75.46M
287.36%
31.10M
-66.96%
690.48K
-98.40%
438.68K
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
Axsome Therapeutics Inc的总收入是多少?
根据Axsome Therapeutics Inc的FY2025财报,总收入达到了638.50M(同比变化385.69M)。
Axsome Therapeutics Inc的流动资产是多少?
根据Axsome Therapeutics Inc的FY2025财报,流动资产为588.99M(同比变化21.42)。
Axsome Therapeutics Inc的总资产是多少?
根据Axsome Therapeutics Inc的FY2025财报,Axsome Therapeutics Inc的总资产为689.80M(同比变化21.34)。
Axsome Therapeutics Inc的总负债是多少?
根据Axsome Therapeutics Inc的FY2025财报,Axsome Therapeutics Inc的总负债为601.51M(同比变化17.60)。
Axsome Therapeutics Inc的总权益是多少?
根据Axsome Therapeutics Inc的FY2025财报,Axsome Therapeutics Inc的总权益为88.30M(同比变化54.86)。
Axsome Therapeutics Inc的净营业收入是多少?
根据Axsome Therapeutics Inc的FY2025财报,Axsome Therapeutics Inc的净营业收入为-171.53M(同比变化32.05)。
Axsome Therapeutics Inc的净投资是多少?
根据Axsome Therapeutics Inc的FY2025财报,Axsome Therapeutics Inc的净投资为-480.00K(同比变化-77.78)。
Axsome Therapeutics Inc的净融资是多少?
根据Axsome Therapeutics Inc的FY2025财报,Axsome Therapeutics Inc的净融资为101.47M(同比变化75.42)。
Axsome Therapeutics Inc的每股收益(EPS)是多少?
根据Axsome Therapeutics Inc的FY2025财报,每股收益(EPS)为-3.68(同比变化38.57)。
Axsome Therapeutics Inc的净利润是多少?
根据Axsome Therapeutics Inc的FY2025财报,净利润为-183.17M(同比变化36.22)。
Axsome Therapeutics Inc的净利润率是多少?
根据Axsome Therapeutics Inc的FY2025财报,净利润率为-28.69(同比变化61.48)。
Axsome Therapeutics Inc的毛利率是多少?
根据Axsome Therapeutics Inc的FY2025财报,毛利率为91.57(同比变化2.07)。
Axsome Therapeutics Inc的债务与资产比率是多少?
根据Axsome Therapeutics Inc的FY2025财报,债务与资产比率为28.20(同比变化-13.39)。
Axsome Therapeutics Inc的股东权益回报率(ROE)是多少?
根据Axsome Therapeutics Inc的FY2025财报,股东权益回报率(ROE)为-252.11(同比变化-8.84)。
Axsome Therapeutics Inc的资产回报率(ROA)是多少?
根据Axsome Therapeutics Inc的FY2025财报,资产回报率(ROA)为-29.11(同比变化41.37)。
Axsome Therapeutics Inc的营业利润是多少?
根据Axsome Therapeutics Inc的FY2025财报,营业利润为-171.53M(同比变化32.05)。